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Summary Retinoblastoma (Rb) tumour-suppressor protein plays a critical role in cell cycle control. Rb
inactivation is a frequent phenomenon in tumours of different cell lineages, in which the absence of Rb protein
has been considered to be a marker of Rb disregulation. We used modern immunohistochemical techniques to
study the expression of Rb protein in a large series of 130 patients with Hodgkin's disease. Simultaneously,
Western blot was used to analyse a more restricted group (12 patients) to confirm the immunohistochemical
results and to clarify the phosphorylation status of Rb protein. As the level of Rb expression varied according
to cell cycle stage, we also performed immunostaining for Ki67, a protein present in proliferating cells. To
make comparison possible, we first characterised the amount and phosphorylation status of Rb protein in
reactive lymphoid tissue and phytohaemagglutinin (PHA)-stimulated lymphocytes. The presence of p53 in
Sternberg-Reed cells was also included in the study, as both proteins (p53 and Rb) have been found to be
closely associated in cell cycle control. PHA-stimulated peripheral blood lymphocytes showed a parallel
increase in Rb and cell cycle progression, together with progressive Rb phosphorylation. In reactive lymphoid
tissue there was also a clear correlation between Rb expression and the Ki67 proliferation index (R=0.96,
P=0.038). When analysing Hodgkin's disease samples, a clear difference emerges between cases of nodular
lymphocyte predominance, which preserve the relationship between Rb and Ki67 expression (r=0.8727,
P=0.000), and classical forms of Hodgkin's disease (nodular sclerosis and mixed cellularity), which display a
strong deviation from this pattern. Two main anomalies were found: (1) One group of21/130 cases with partial
or total loss of Rb protein expression, which could reflect the existence of genetic alterations, or an altered
transcriptional or translational regulation of Rb gene. (2) Another group with an abnormally high Rb/Ki67
ratio, which could support conflicting interpretations: (i) excess Rb protein for controlling cell cycle
progression; or (ii) adhesion of Rb protein to other cellular or viral proteins, such as p53 and MDM2. The
results of this study indicate an anomalous pattern of expression of Rb in classical forms of Hodgkin's disease,
and suggest the possibility of undertaking functional studies (EIA adhesion, p16 expression) with the aim of
better characterising the status of Rb protein, and correlating these findings with clinical course in Hodgkin's
disease patients.
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Retinoblastoma susceptibility gene (Rb) is a tumour-
suppressor gene that codes for a nuclear phosphoprotein
which plays a key role in cell cycle regulation (Buchkovich et
al., 1989; Mihara et al., 1989; Chen et al., 1989). Although
Rb protein is expressed in all the human organs examined,
this expression is at heterogeneous levels which seem to be
related to the growth and differentiation status of each cell
type (Cordon-Cardo and Richon, 1994).
Rb acts as a signal transducer, connecting the cell cycle
clock with transcriptional machinery. Levels of Rb protein
are modified during the cell cycle, as well as its phosphoryla-
tion state. Rb protein in its hypophosphorylated state works
as a negative regulator of the cell cycle by forming complexes
with transcription factors such as E2F (Challeppan et al.,
1991). This interaction sequesters E2F, which is known to
stimulate the expression of genes required for the S-phase
transition. When Rb is phosphorylated by the cyclin/cyclin-
dependent kinase complexes (CDKs), it becomes inactivated
and permits the G,/S transition (Lees et al., 1991; Lin et al.,
1991).
Rb is inactivated in many human malignancies and virally
induced cell transformations including sarcomas, carcinomas
of the bladder, lung, breast, prostate, parathyroid, liver and
malignancies of the blood and brain (Lee et al., 1990;
Ginsgerg et al., 1991; Horowitz et al., 1990, 1991; Ishikawa et
al., 1991; Xu et al., 1991a; Shimizu et al., 1994). While benign
tumours usually express high levels of Rb protein, low or
undetectable levels of the protein have been shown in high-
grade invasive neoplasias (Ishikawa et al., 1991; Xu et al.,
1991a; Kornblau et al., 1994). These Rb-negative tumours
have been shown to follow a more aggressive clinical course
(Cance et al., 1990; Xu et al., 1991a; Kornblau et al., 1994;
Cordon-Cardo et al., 1992).
Several viral oncoproteins, such as SV40 T antigen, EIA,
HPV-E7 and EBNA-5, bind specifically to hypophosphory-
lated Rb, resulting in increased proliferation of the infected
cells (DeCaprio et al., 1988; Whyte et al., 1988; Dyson et al.,
1989; Egan et al., 1989; Slebos et al., 1994; Szekely et al.,
1993)
Very little is known about the status of Rb in Hodgkin's
disease (HD). Previous findings by our group in frozen
sections show weak Rb expression of the protein in roughly
two-thirds of HD cases studied (Martinez et al., 1993).
Owing to the role of Rb protein in cell cycle regulation,
and the absence of previous studies of Rb expression in HD,
we studied its expression in a large group of cases of HD.
This was undertaken simultaneously with study of the
proliferation index, as defined by monoclonal antibody
MIBI (equivalent to Ki67 for paraffin sections), since
previous studies in reactive conditions and NHLs have
shown that there is a parallel increase of both parameters
(Rb and Ki67), the Rb/Ki67 ratio being more important than
the Rb value alone. p53 presence in Hodgkin and Sternberg-
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Reed (H and SR) cells has also been included in the study,
since both proteins (p53 and Rb) have been found to be
closely associated in cell cycle control (Williams et al., 1994;
White 1994). For this purpose, we made use of heat-induced
retrieval antigen techniques, which lower the reactivity
threshold in paraffin section immunohistochemistry. The
results were analysed using a computerised system for
quantifying and comparing results.
Materials and methods
Biopsies
A total of 21 paraffin-embedded biopsies from patients with
Hodgkin's lymphoma were obtained from the 'Virgen de la
Salud' Hospital (Toledo), 35 from the Department of Cellular
Pathology of the John Radcliffe Hospital, Oxford, and 118
from the Spanish Hodgkin's Disease Register. Case selection
was based on the availability of paraffin-embedded tissue,
which was fixed in neutral formalin for 24 h.
Of these, 155 cases gave valid observations for Rb, 136 for
Ki67 and 131 for p53 protein expression. In 130 cases the
simultaneous expression of Ki67 and Rb was considered
valid. The expression of p53 was also included in 127 cases.
Formalin-fixed sections of each specimen were stained with
haematoxylin and eosin and examined to determine their
histological type and number of SR cells. The number of H
and SR cells was evaluated semi-quantitatively, from 1+
(low) to 3 + (high) by two independent observers (MAP and
MSB).
Four samples of paraffin-embedded reactive tonsil were
included in the study as a control of the pattern of expression
of Rb protein and Ki67 proliferation index in non-tumoral
reactive tissue.
Peripheral blood lymphocytes (PBLs)
Normal peripheral blood was obtained by venipuncture from
volunteer healthy donors. PBLs were isolated by Histopaque
(Sigma Diagnostic) density gradient centrifugation, and
washed in RPMI-1640 medium. Cells were kept at 37°C in
a 5% carbon dioxide humidified incubator in cell culture
flasks, at 2 x 106 cells ml-' of RPMI-1640 medium,
supplemented with 10% fetal calf serum, 2 mM L-glutamine
and 2% phytohaemagglutinin (PHA) (Gibco, BRL). Aliquots
of the activated cells were harvested every 24 h and prepared
for Western blotting and flow cytometry analysis.
Antibodies
Tumours were analysed using the monoclonal antibody
(MAb) Rb PMG3-245 (PharMingen), which recognises an
epitope between amino acids 300-380 of the human Rb
protein. This antibody binds both phosphorylated and
unphosphorylated forms of the Rb protein. Tumours were
also analysed with the polyclonal CM 1 antibody
(Novocastra), which recognises mutant and wild-type p53
protein.
The growth rate was studied by immunostaining with
MIBI MAb (Immunotech). This antibody is equivalent to
Ki67 for paraffin-embedded microwave-processed sections
(Cattoretti et al., 1992).
Microwave oven processing for antigen retrieval
Paraffin sections were dewaxed in xylene and rehydrated in
graded alcohols. Rehydrated slides were placed in plastic
Coplin jars filled with a 0.01 M trisodium citrate solution and
incubated twice for 7 min at 700 W in a microwave oven.
During microwave processing sections must always be
covered by solution. The sections were allowed to cool
down for approximately 15 min, washed with Tris-buffered
saline (TBS) and immunostained according to standard
protocols.
Immunostaining
All three antibodies were detected by means of the alkaline
phosphatase/anti-alkaline phosphatase (APAAP) technique
using Fast Red as chromogen. Levamisole was employed to
inhibit endogenous alkaline phosphatase. Slides were counter-
stained with haematoxylin.
The simultaneous staining of known Rb-, p53- and Ki67-
positive cases were used as positive controls. An internal
control for each case was provided by the Ki67 reactivity
always present in some reactive lymphocytes. The incubation
of parallel slides omitting the first antibody was performed as
a negative control.
Quantitative studies
Quantitative immunohistochemical investigation with the
quantitative nuclear antigen application of the computerised
analyser system (CAS 200) was used to score individual
nuclei for the presence of Rb and p53 nuclear protein
(Martinez et al., 1993). This program measured the
percentage of total optical density of positive cell nuclei in
tissue sections, i.e. the intensity of nuclear staining in
comparison with total nuclear area (Martinez et al., 1993;
Figge et al., 1991; Cance et al., 1990).
The growth fraction was quantified by the quantitative
proliferation index application of the CAS 200 analyser. This
program measures the percentage of proliferating cells in a
tissue section.
Representative fields down to a minimum of 30 000 ,um2
were selected (approximately 5 fields with a 45 x objective
and 10 x ocular lenses). Sectional analysis was carried out at
random by one of the authors (MSB), focusing on tumoral
areas.
Statistics
Spearman's rank correlation coefficient was used to evaluate
the strength of the relationship between the three parameters
of Rb, Ki67 and p53 immunostaining. A contrast-free
parametric test of averages of multiple independent samples
(Kruskal-Wallis) was run to compare the levels of Rb, p53
and Ki67 and to correlate them with the number of H and
SR cells.
Western blotting (WB) analysis
The cases of WB analysis were selected on the basis of the
availability of frozen tissue in the tissue bank of the 'Virgen
de la Salud' Hospital. The histopathological subtype
distribution was as follows: five cases of Nodular Sclerosis
(NS-HD), four cases ofmixed cellularity (MC-HD) and three
cases of nodular lymphocyte predominance (NLP-HD).
Fragments of tumour tissue from 12 cases of HD were cut,
washed with phosphate-buffered saline (PBS) and subjected
to protein extraction protocols. Aliquots from DEV (HD cell
line, Poppema), Saos-2 (osteosarcoma cell line defective for
Rb protein, ATCC), PBLs and PHA-stimulated PBLs were
washed twice with cold PBS before protein extraction
procedure. Protein was extracted with a triple detergent
lysis buffer [50 mm Tris-Cl (pH 8.0), 150 mM sodium
chloride, 0.02% sodium azide, 0.1% sodium dodecyl
sulphate (SDS), 1% Nonidet P-40 (NP-40), 0.5% sodium
deoxycholate, phenylmethylsulphonyl fluoride (PMSF)
100 jug ml-', aprotinin 50 jug ml-'] for 30 min at 4°C.
Extracts were cleared by centrifugation.
Extracted protein was resolved by 7.5% sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred to nitrocellulose-ECL (Amersham) according to
the manufacturer's instructions. The blots were blocked
overnight with 5% bovine serum albumin in PBS at 37°C.
Rb protein was detected by Rb MAb PMG3-245 (PharMin-
gen), followed by incubation with goat anti-mouse coupled to
horseradish peroxidase (Amersham). Blots were developed
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using the chemiluminescence ECL detection kit (Amersham).
Protein from HD was incubated with actin MAb (Amer-
sham) to control the amount and quality of the protein
extracted.
Flow cytometry
PHA-activated lymphocytes were prepared for the study of
nuclear DNA content by flow cytometry, using the
CycleTEST DNA reagent kit (BD Immunocytometry
Systems). Sample preparation, data acquisition and analysis
have been described elsewhere (Vindelov et al., 1983).
Results
Non-neoplastic tissues
Reactive tonsils and normal peripheral blood lymphocytes
were included in the study to establish the normal levels of
expression of Rb protein, and its relationship with the
proliferation index in non-neoplastic lymphoid tissues.
Reactive tonsil tissue was immunostained with MAbs for
the Rb and Ki67 proteins. The nuclei oflarge germinal centre
cells and proliferating cells in the interfollicular area exhibit
simultaneous staining for Ki67 and Rb proteins. The
relationship between the expression of both proteins
(measured by the CAS200 image analyser) was high and
statistically significant (r =0.96, P =0.038). This parallelism in
the expression of both proteins is also observed in tonsilar
epithelial suprabasal cells (Figures la and b).
Western blot (WB) analysis of PHA-stimulated lympho-
cytes showed an increase in the amount and degree of Rb
protein phosphorylation along cell cycle progression (Figure
2a and Table I). Protein extracted from reactive tonsils
showed a high level of Rb protein, and it was possible to
identify multiple bands corresponding to both unphosphory-
lated and phosphorylated forms. DEV and Saos-2 cell lines
were included as positive and negative controls for Rb
protein.
Hodgkin's disease samples
Rb detection Immunohistochemical (IHC) analysis of HD
cases showed Rb protein expression in 147 of 155 cases of
HD. Rb protein was mainly expressed by H and SR cells
with a strong nuclear signal. No cytoplasmic signal was
identified in any case. Although in the majority of cases there
were endothelial, histiocytes and lymphocytes with Rb
staining, most of the signal measured came from the larger
H and SR cells, which have a stronger staining than reactive
cells (Figure 3a). Rb protein expression was measured by the
CAS200 analyser, focusing on tumour areas. The values
obtained range from 1 to 60% of positive staining intensity.
There were 8/155 cases with an undetectable Rb signal.
When levels of Rb protein were compared according to the
percentage of SR cells, cases with a high number of H and
SR cells were found to have higher levels of Rb protein.
Cases with low or medium quantities of SR cells have similar
levels of Rb protein (Table II). The differences in Rb protein
levels according to histological type were not statistically
significant (Table III).
WB analysis of Rb protein in 12 cases of HD (five NS-
HD, four MC-HD, three NLP-HD), showed variable
degrees of expression, and was undetectable in two cases.
The signal obtained in protein extracted from HD cases was
a
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Figure 2 (a) Western blotting analysis of Rb protein in non-
tumoral samples: PHA-stimulated PBLs and tonsil. DEV, positive
control (Hodgkin cell line); Saos-2, negative control (Rb defective
cell line). (b) Western blotting analysis of Rb protein in seven
samples of HD. Detection of actin was included as a control of
the amount and quality of loaded protein.
Figure 1 (a) Immunostaining of reactive tonsil with Rb MAb
showing a generalised pattern of staining in germinal centre cells.
(b) Ki67 immunostaining in a germinal centre of a reactive tonsil.
Table I Cell cycle analysis of PBLs after stimulation with PHA
PBLs+ PBLs+ PBLs+ PBLs+
PHA PHA PHA PHA
Oh 24h 48h 72h
GO/GI (%) 99.6 98.3 90.0 77.0
S (%) 0.2 1.1 9.5 19.1
G2/M (%) 0.2 0.6 0.5 3.9
Cells were analysed using the Cellfit software program ofthe Facsort
cytometer. The results are presented as the percentage ofcells in each
cell cycle phase (GO/GI), S or G2/M). PBL, peripheral blood
lymphocyte. PHA, phytohaemagglutinin.Rb expression in Hodgkin's disease
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Table II Ki67, p53 and Rb expression according to SR cells
frequency
SR+ SR+ + SR+++ P(K-W)
Ki67 0.1243
n 13 86 37
Mean 10.0889 10.1147 14.0969
s.e. 3.1924 1.0407 2.2670
p53 0.0021
n 13 82 37
Mean 0.889 2.6800 3.9844
s.e. 0.4835 0.3680 0.8127
Rb 0.0049
n 13 94 40
Mean 11.2333 9.3720 14.8906
s.e. 2.6784 0.9107 1.4940
SR, Steinberg-Reed cells; P, significance; K-W, Kruskal-Wallis;
n, number ofcases; Mean, mean value; s.e., standard error.
Ki67 detection Ki67 expression was observed in all HD
cases analysed. A high percentage of large cells (H and SR)
were stained in all cases. Frequent staining of small reactive
cells was also seen (Figure 3b). Measurement of the
proliferation index with the CAS200 analyser was carried
out by focusing on tumour areas, although the percentage of
positive cells was partially determined by the reactive cells
surrounding SR cells. The overall value of Ki67 reactivity
varied from 1 to 40% (Tables II and III).
p53 detection P53 protein expression was analysed using
polyclonal antibody CM1. p53 immunostaining was observed
in 108 of 131 cases of HD, almost completely restricted to H
and SR cells (Figure 3c), although a weak signal could be
identified in some sporadic smaller cells. The number of
tumour cells immunostained varied from case to case. The
levels of p53 expression, as quantified by the CAS200
analyser, ranged from 0 to 23.5% of protein staining. These
values correspond to the intensity of staining. Those cases
with a greater number of SR cells also showed higher levels
of p53 immunostaining (Table II).
Figure 3 (a) Rb immunostaining in H and SR cells in a HD
case. (b) Immunostaining for Ki67 is present in H and SR cells as
well as in small reactive cells. (c) p53 immunostaining in H and
SR cells in a HD case.
weaker than that obtained from tonsil tissue. The levels of
Rb protein detected by WB correspond with the IHC signal,
except in two WB-negative cases in which immunostaining
showed SR-positive cells. Phosphorylation status varied from
case to case. In four of these the signal corresponded to the
un- or hypophosphorylated form of the protein. There was a
rough connection between growth fraction and phosphoryla-
tion status, and most cases with hypophosphorylated Rb
show low Ki67 labelling. Actin expression was included as a
control for the amount and integrity of protein loaded in
each lane (Figure 2b).
Rb/Ki67 and Rb/p53 relationship in HD
The existence of an overall relationship between the three
parameters (Rb, p53 and Ki67 protein expression) was
investigated using Spearman's rank correlation coefficient.
Taking all the cases into consideration, Rb was not found to
be related to p53 (r=0.288, P=0.001) or Ki67 (r=0.2892,
P=0.001) (Table IV and Figure 4a).
When different histopathological types are taken into
consideration, some differences appear: NLP-HD cases show
a strong relation between Rb and Ki67 (r=0.8727, P= 0.000)
(Figure 4b and Table IV). This relationship was not found in
the classical forms of HD (NS-HD and MC-HD) (Table IV).
When the relationship between parameters was analysed
according to the percentage of SR cells (Table V), two main
relationships were found. Rb and Ki67 were clearly
correlated in those cases with a small number of H and SR
cells (r=0.6788, P=0.022), a finding probably overlapping
that found in NLP-HD. Nevertheless, in cases with a high
number of SR cells, the main association was between the
expression of Rb and p53 proteins (r=0.4296, P=0.010).
Discussion
This study examined the expression of Rb protein in non-
neoplastic lymphoid tissue and in a large series of HD cases.
In the attempt to establish Rb protein levels in non-
neoplastic lymphoid cells and tissues, its expression was
studied in peripheral blood lymphocytes (PBLs) and reactive
tonsils. We found that, after PHA stimulation, the amount ofRb expression in Hodgkin's disease
rt M Sanchez-Beato et al
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Table III Ki67, p53 and Rb expression according to Hodgkin's disease histological subtype
NLP NS MC LD P (K- W)
Ki67 0.3154
n 12 73 45 6
Mean 10.6364 12.4145 9.0026 14.34
s.e. 3.1657 1.4613 1.2921 4.2265
p53 0.0672
n 14 68 44 5
Mean 1.1545 3.3093 2.4237 4.300
s.e. 0.3533 0.5036 0.5094 2.2032
Rb 0.0213
n 14 85 50 6
Mean 8.0909 12.6726 8.6737 15.2400
s.e. 2.2241 1.0969 1.2243 3.5572
NLP, nodular lymphocyte predominance; NS, nodular sclerosis; MC, mixed cellularity; LD,
lymphocyte depleted; P, significance; K-W, Kruskal-Wallis; n, number of cases; Mean, mean value;
s.e., standard error.
Table IV Relationship between Rb, p53 and
according to diagnosis
Ki67: Distribution a
70
Rb-p53 Rb-Ki67
Global r=0.2880 r=0.2892
P=0.001 P=0.001
n=127 n=130
NLP r=-0.0886 r =0.8727
P=0.773 P=0.000
n=13 n=11
NS r =0.2118 r=0.1718
P=0.085 P=0.149
n=67 n=72
MC r=0.4022 r=0.2131
P=0.008 P=0.181
n=42 n=41
LD r=0.5643 r =0.580
P=0.322 P=0.913
n=5 n=6
r, Correlation index; P, significance; n, number of cases; NLP,
nodular lymphocyte predominance; NS, nodular sclerosis; MC, mixed
cellularity; LD, lymphocyte depleted
60
50
40
.0
30
20
10
70
60
-o
Rb protein increases in PBLs parallel with cell cycle
progression. At the same time this Rb protein shows
progressive phosphorylation. This confirms previous reports
(Buchkovich et al., 1989; Chen et al., 1989; Mihara et al.,
1989) and other studies showing variation in Rb protein
levels in B and T lymphocytes, when cells entered the S-phase
in response to mitogens (Martinez et al., 1993; Tereda et al.,
1991). This increase in Rb protein along the cell cycle has
also been detected in other cell types (Xu et al., 1991b), and is
also found in this study in reactive tonsils, which show a
similar pattern of staining for Rb and Ki67. Rb protein
appears to be preferentially expressed in proliferating cells
located in germinal centres and suprabasal layers of the
epithelium (Martinez et al., 1993; Mateo et al., 1995).
In the light of this parallel increase of Rb protein levels
and Ki67 proliferation index, we studied both parameters in
a large number of cases of HD (130). Rb protein
immunostaining was found in most cases, distributed mainly
in H and SR cells. Although in almost every case Rb protein
was also found in benign cells (endothelial, histiocytes,
germinal centre lymphocytes), H and SR cells frequently
showed a stronger intensity (see Figure 3). WB analysis was
also undertaken in a small subset of cases of HD, selected on
the basis of the availability of frozen tissue, to confirm the
IHC data. The results confirm that the labelled protein has a
105-11O kDa molecular weight. Although the intensity of
the signal varied from case to case, it was always weaker
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Figure 4 Image quantification of Rb and Ki67 expression. (a)
There is no statistical relationship between these two parameters,
taking all the HD cases into consideration. (b) NLP cases (*)
show a strong relationship between Rb and Ki67 (r=0.8727,
P=0.000), similar to that of tonsil samples (El) (r=0.96,
P=0.038).
than that obtained for reactive tonsils. An overall relation
was found between IHC and WB data, except in two cases
which showed definite IHC reactivity but were negative by
WB, probably due to dilution of the protein from SR cells in
the total protein extracted from the benign cells present. This
problem is always present when molecular techniques are
applied to the study of HD. Indeed, an analysis of our
results suggests that IHC techniques are more reliable in the
analysis of the status of tumour cells in HD, since they
constitute a minority subpopulation. Unfortunately, immu-
nostaining cannot provide information about the phosphor-
ylation status of the Rb protein, which can currently only be
provided by WB.
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Table V Relationship between Rb, p53 and Ki67: Distribution
according to number of SR cells
Rb-p53 Rb-Ki67
SR+ r=-0.0323 r =0.6788
P=0.929 P=0.022
n=10 n=11
SR+ + r=0.2167 r=0.1798
P=0.051 P=0.102
n=82 n=84
SR+ + + r=0.4296 r=0.2935
P=0.010 P=0.087
n=35 n=35
SR, Sternberg- Reed cells; r, correlation index; P, significance; n,
number ofcases.
Unlike the weak relation found in this study between the
levels of Ki67 and Rb expression in HD cases as a whole, the
group of NLP-HD cases showed a significant and strong
relationship between these two proteins. This confirms that
NLP-HD is probably a different disease with distinct
molecular pathogenesis than the classical forms of HD.
Significantly, NLP-HD cases show a similar ratio between
these two proteins to that found in benign conditions,
suggesting the absence of any Rb disregulation.
This contrasts with classical forms of HD, where the
normal relation between Rb and Ki67 has been lost. When
analysing this Rb/Ki67 relation, it was possible to identify
two main deviations from the normal pattern:
(1) a subset of cases showed undectable (8/130) or low (13/
130) Rb protein levels in association with a high Ki67
proliferation index. This could indicate a loss of Rb
expression in H and SR cells, similar to that described in
tumours of different cell lineages. Rb deletion has been
described in glioblastomas and CLL (Venter et al., 1991;
Kornblau et al., 1994; Stilgenbauer et al., 1993),
mutation in isolated cases of leukaemia and in a wide
array of other tumours (Lee et al., 1990; Horowitz et al.,
1990, 1991; Ishikawa et al., 1991; Xu et al., 1991a). The
hallmark of all these tumours with Rb disregulation is
the absence of Rb protein expression, similar to that
found in this small group of cases of HD. Previous
cytogenetic studies in untreated HD cases have shown
that loss of chromosome 13 was one of the most
frequent findings (Tilly et al., 1991; Schouten et al.,
1989). This selective loss of chromosome 13 suggests the
possibility of loss of heterozygosity of Rb (located in
13ql4) as a step in HD development, and it may explain
the absence of Rb protein expression in a subset of the
HD cases analysed in the present study. Loss of Rb
expression could also be secondary to gene mutation, or
to an altered pattern of transcriptional or translational
control of Rb, resulting in reduced expression of the
protein (Korblau et al., 1994).
(2) A second group ofcases exhibit an abnormally high Rb/
Ki67 ratio, when compared with PHA-stimulated
lymphocytes or reactive lymphoid tissue. This could be
interpreted in different ways: an excess of Rb protein
could be inducing cell cycle arrest, which is in agreement
with the important role of Rb protein in the control of
G-S transition. Alternatively, the nuclear accumulation
of Rb could be dependent on its interaction with other
proteins, which are able to stabilise it. SR cells have been
claimed to display large amounts of p53 and MDM2
(Martinez et al., 1995), two proteins which interact with
Rb (Szekely et al., 1993; Xiao et al., 1995). Some of our
findings could point towards some degree of p53-Rb
interaction in a group of cases characterised by the
presence of a high number of SR cells, since these cases
show simultaneous increase in levels of Rb, p53 and
Ki67 proteins. It has recently been shown that MDM2
binds to Rb, inactivating it in a way similar to viral
proteins (Xiao et al., 1995). It is not yet known how this
MDM2 inactivation is associated with the stabilisation
or degradation of the protein. An analysis of our results
(data not shown) does not confirm a simultaneous
labelling of H and SR cells for Rb and MDM2, since the
percentage of Rb-positive cells vastly exceeds that of
MDM2-positive cells.
High levels of Rb protein were found in two previous
studies, both on lymphoproliferative lesions. Thus in NHLs
(Martinez et al., 1993) and CLL (Kornblau et al., 1994) a
significant proportion of cases showed that same anomalous
Rb accumulation. In neither case has an explanation been
suggested for this finding.
The results of this study point towards an anomalous
pattern of expression of Rb in the classical forms of HD.
These findings suggest the possibility of undertaking
functional studies (EIA adhesion, p16 expression) aimed at
improved characterisation of the status of Rb protein, and
correlating these findings with the clinical course in HD
patients.
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